Pub Date : 2026-01-24DOI: 10.1016/j.advms.2026.01.002
Artur Szumowski, Tomasz Wasiluk, Magdalena Średzińska, Kamila Rybińska, Mateusz Dziemiańczuk, Paulina Radziwon, Michał Kuźma, Piotr Radziwon
Purpose: Granulocyte concentrates (GCs) are crucial in preventing and treating hazardous infections in neutropenic patients with hematological malignancies. Our study goal was to evaluate the impact of various collection and preparation methods on the quality of GCs.
Materials and methods: Our study included 30 GCs that were collected either by leukapheresis (group L), by standard buffy coat pooling (group S), or by using the Reveos system (group R). All studied GCs were irradiated with gamma rays and stored for 24 h at room temperature without agitation. Laboratory tests included the assessment of leukocyte (WBC), neutrophil, lymphocyte and monocyte counts, pH, cell viability, phagocytosis, and the expression of CD11b, CD62L, CD66b and CXCR4 molecules.
Results: We showed that GCs prepared using different methods differed primarily in terms of cell counts, cell viability, and the CD11b, CD62L and CXCR4 expression. We also observed that gamma irradiation expectedly reduced the lymphocyte count, whereas 24-h storage drastically reduced cell viability. An additional effect of the preparation method on GCs susceptibility to quality changes due to gamma rays and 24-h storage was noticed as well.
Conclusions: Our research indicates that apheresis-derived granulocytes and pooled GCs do not differ enough to not consider more frequent use of the latter in daily clinical practice. Moreover, we concluded that gamma irradiation does not worsen the quality of granulocyte components, and freshly collected GCs should be preferred.
{"title":"Pooled granulocyte component-a worthy rival to the apheresis product?","authors":"Artur Szumowski, Tomasz Wasiluk, Magdalena Średzińska, Kamila Rybińska, Mateusz Dziemiańczuk, Paulina Radziwon, Michał Kuźma, Piotr Radziwon","doi":"10.1016/j.advms.2026.01.002","DOIUrl":"10.1016/j.advms.2026.01.002","url":null,"abstract":"<p><strong>Purpose: </strong>Granulocyte concentrates (GCs) are crucial in preventing and treating hazardous infections in neutropenic patients with hematological malignancies. Our study goal was to evaluate the impact of various collection and preparation methods on the quality of GCs.</p><p><strong>Materials and methods: </strong>Our study included 30 GCs that were collected either by leukapheresis (group L), by standard buffy coat pooling (group S), or by using the Reveos system (group R). All studied GCs were irradiated with gamma rays and stored for 24 h at room temperature without agitation. Laboratory tests included the assessment of leukocyte (WBC), neutrophil, lymphocyte and monocyte counts, pH, cell viability, phagocytosis, and the expression of CD11b, CD62L, CD66b and CXCR4 molecules.</p><p><strong>Results: </strong>We showed that GCs prepared using different methods differed primarily in terms of cell counts, cell viability, and the CD11b, CD62L and CXCR4 expression. We also observed that gamma irradiation expectedly reduced the lymphocyte count, whereas 24-h storage drastically reduced cell viability. An additional effect of the preparation method on GCs susceptibility to quality changes due to gamma rays and 24-h storage was noticed as well.</p><p><strong>Conclusions: </strong>Our research indicates that apheresis-derived granulocytes and pooled GCs do not differ enough to not consider more frequent use of the latter in daily clinical practice. Moreover, we concluded that gamma irradiation does not worsen the quality of granulocyte components, and freshly collected GCs should be preferred.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":"27-39"},"PeriodicalIF":2.6,"publicationDate":"2026-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146049744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-23DOI: 10.1016/j.advms.2026.01.003
Karol Witold Nowak, Aleksander Siniarski, Alicia Del Carmen Yika, Aleksandra Karcinska, Anna Matrejek, Konrad Stepien, Jadwiga Nessler, Grzegorz Gajos, Jaroslaw Zalewski
Purpose: We sought to investigate whether left ventricular (LV) contractility and endothelial dysfunction in diabetic patients with ischemic heart failure (HF) are associated with enhanced thrombin generation and altered fibrin clot properties compared with individuals without HF.
Materials and methods: The study included 85 HF patients with type 2 diabetes (T2DM) and ischemic heart disease (IHD). Based on echocardiographic examination, 39 (45.9 %) patients were identified as having LV ejection fraction (LVEF) of <40 % (HFrEF) while 46 patients (54.1 %) of ≥50 % (HFpEF). The control group (n = 43) consisted of diabetic and IHD participants without HF (non-HF). In all groups, endogenous thrombin potential (ETP), fibrin clot permeability (Ks), brachial artery flow-mediated dilation (FMD), and nitroglycerin-mediated dilatation (NMD) were assessed.
Results: HFrEF and HFpEF patients had less permeable fibrin clots than non-HF by 45.4 % and by 14.6 %, respectively (P < 0.05 both). HFrEF patients had higher ETP by 14.4 % (P = 0.004), lower Ks by 16.9 % (P = 0.037) and lower NMD by 34.7 % (P = 0.001) without differences in FMD as compared with HFpEF. Multivariable analysis adjusted for fibrinogen levels showed that lower LVEF (β-coefficient -0.195, 95 % confidence interval [CI] for β-coefficient -0.385 to -0.015), reduced NMD (β-coefficient -0.230, 95 %CI -0.399 to -0.061), and increased total cholesterol level (β-coefficient 0.286, 95 %CI 0.108-0.464) influenced enhanced ETP in HF population.
Conclusions: In diabetic patients with IHD, the diagnosis of HF is associated with more dense fibrin clots. HF patients with reduced versus preserved LVEF have shown enhanced thrombin generation and reduced clot permeability. Impairment of both LV systolic and vascular vasodilator function affected thrombin generation.
{"title":"The prothrombotic potential of diabetic patients with ischemic heart failure is associated with impaired left ventricular contractility and endothelial dysfunction.","authors":"Karol Witold Nowak, Aleksander Siniarski, Alicia Del Carmen Yika, Aleksandra Karcinska, Anna Matrejek, Konrad Stepien, Jadwiga Nessler, Grzegorz Gajos, Jaroslaw Zalewski","doi":"10.1016/j.advms.2026.01.003","DOIUrl":"10.1016/j.advms.2026.01.003","url":null,"abstract":"<p><strong>Purpose: </strong>We sought to investigate whether left ventricular (LV) contractility and endothelial dysfunction in diabetic patients with ischemic heart failure (HF) are associated with enhanced thrombin generation and altered fibrin clot properties compared with individuals without HF.</p><p><strong>Materials and methods: </strong>The study included 85 HF patients with type 2 diabetes (T2DM) and ischemic heart disease (IHD). Based on echocardiographic examination, 39 (45.9 %) patients were identified as having LV ejection fraction (LVEF) of <40 % (HFrEF) while 46 patients (54.1 %) of ≥50 % (HFpEF). The control group (n = 43) consisted of diabetic and IHD participants without HF (non-HF). In all groups, endogenous thrombin potential (ETP), fibrin clot permeability (Ks), brachial artery flow-mediated dilation (FMD), and nitroglycerin-mediated dilatation (NMD) were assessed.</p><p><strong>Results: </strong>HFrEF and HFpEF patients had less permeable fibrin clots than non-HF by 45.4 % and by 14.6 %, respectively (P < 0.05 both). HFrEF patients had higher ETP by 14.4 % (P = 0.004), lower Ks by 16.9 % (P = 0.037) and lower NMD by 34.7 % (P = 0.001) without differences in FMD as compared with HFpEF. Multivariable analysis adjusted for fibrinogen levels showed that lower LVEF (β-coefficient -0.195, 95 % confidence interval [CI] for β-coefficient -0.385 to -0.015), reduced NMD (β-coefficient -0.230, 95 %CI -0.399 to -0.061), and increased total cholesterol level (β-coefficient 0.286, 95 %CI 0.108-0.464) influenced enhanced ETP in HF population.</p><p><strong>Conclusions: </strong>In diabetic patients with IHD, the diagnosis of HF is associated with more dense fibrin clots. HF patients with reduced versus preserved LVEF have shown enhanced thrombin generation and reduced clot permeability. Impairment of both LV systolic and vascular vasodilator function affected thrombin generation.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":"19-26"},"PeriodicalIF":2.6,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146045988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-17DOI: 10.1016/j.advms.2026.01.001
Çiğdem Arslan Alıcı, Baran Tokar
Purpose: This study evaluated the effectiveness of subureteric injection (SUI) compared to ureteral reimplantation in treating vesicoureteral reflux (VUR) among children, focusing on whether SUI reduces the need for surgical interventions, especially in complex cases.
Method: We retrospectively analysed 132 children diagnosed with VUR. We divided the patients into two groups: Group 1 - only VUR cases (n = 65) and Group 2 - complex cases (n = 67). We diagnosed VUR and complex pathologies by voiding cystourethrography (VCUG) and cystoscopic examination. VUR was graded according to the International Reflux Study Committee classification system. SUI and intravesical ureteroneocystostomy (UNC) were used as surgical treatment methods.
Results: In Group 2, complex pathologies included duplex renal collecting systems (1.6 %), bladder diverticulum (11.4 %), bladder trabeculation (27.8 %), and posterior urethral valves (18 %). SUI was performed in 48.5 % of patients, with 22.7 % requiring reimplantation after SUI, while 28.8 % underwent direct reimplantation. Success rates of SUI (65.6 %) and reimplantation (70.6 %) were similar (p = 0.68), though lower in children aged 0-2 years with high-grade VUR (45 % for Grade 5) and renal scarring (48 %). Mean recurrence times were 8.4 ± 3.2 months for SUI and 9.1 ± 3.8 months for reimplantation.
Conclusions: The success of SUI and ureteral reimplantation was comparable in both simple and complex cases, suggesting SUI is a viable first-line option, particularly in patients older than 2 years with low-grade reflux. However, further studies are needed to confirm these findings.
{"title":"Subureteric injection in complex vesicoureteral reflux in pediatric patients: a retrospective observational study.","authors":"Çiğdem Arslan Alıcı, Baran Tokar","doi":"10.1016/j.advms.2026.01.001","DOIUrl":"10.1016/j.advms.2026.01.001","url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluated the effectiveness of subureteric injection (SUI) compared to ureteral reimplantation in treating vesicoureteral reflux (VUR) among children, focusing on whether SUI reduces the need for surgical interventions, especially in complex cases.</p><p><strong>Method: </strong>We retrospectively analysed 132 children diagnosed with VUR. We divided the patients into two groups: Group 1 - only VUR cases (n = 65) and Group 2 - complex cases (n = 67). We diagnosed VUR and complex pathologies by voiding cystourethrography (VCUG) and cystoscopic examination. VUR was graded according to the International Reflux Study Committee classification system. SUI and intravesical ureteroneocystostomy (UNC) were used as surgical treatment methods.</p><p><strong>Results: </strong>In Group 2, complex pathologies included duplex renal collecting systems (1.6 %), bladder diverticulum (11.4 %), bladder trabeculation (27.8 %), and posterior urethral valves (18 %). SUI was performed in 48.5 % of patients, with 22.7 % requiring reimplantation after SUI, while 28.8 % underwent direct reimplantation. Success rates of SUI (65.6 %) and reimplantation (70.6 %) were similar (p = 0.68), though lower in children aged 0-2 years with high-grade VUR (45 % for Grade 5) and renal scarring (48 %). Mean recurrence times were 8.4 ± 3.2 months for SUI and 9.1 ± 3.8 months for reimplantation.</p><p><strong>Conclusions: </strong>The success of SUI and ureteral reimplantation was comparable in both simple and complex cases, suggesting SUI is a viable first-line option, particularly in patients older than 2 years with low-grade reflux. However, further studies are needed to confirm these findings.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":"40-45"},"PeriodicalIF":2.6,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146002837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-23DOI: 10.1016/j.advms.2025.12.002
Joanna Pancewicz , Paweł Golec , Anetta Sulewska , Radoslaw Charkiewicz , Wieslawa Niklinska , Piotr Michal Chodorowski , Miroslaw Kozlowski
Purpose
The Wnt/β-catenin signaling pathway is frequently deregulated in various malignancies, including non-small cell lung cancer (NSCLC). This study aimed to evaluate the expression levels of genes encoding ligands that are typically associated with the non-canonical Wnt/β-catenin pathways, specifically, WNT-4, WNT-5A, WNT-7A, WNT-11, and WNT-16 in NSCLC.
Materials and methods
The analysis was conducted on 80 matched pairs of tumor and adjacent non-cancerous lung tissues. Quantitative gene expression analysis was performed using real-time polymerase chain reaction (qPCR).
Results
The results revealed a consistent reduction in the expression of all investigated genes across NSCLC samples and their respective histological subtypes. Notably, elevated WNT-7A gene expression was observed between clinical early (IA) and intermediate IIA stages of NSCLC.
Conclusions
These findings suggest that alterations in the expression of non-canonical Wnt/β-catenin pathway ligands are integral to lung carcinogenesis and may play a critical role in the development of NSCLC. The observed changes in WNT-7A expression between IA and IIA stages of NSCLC further indicate its potential involvement in tumor progression.
{"title":"Evaluating the prognostic value of Wnt signaling pathways in non-small cell lung cancer patients","authors":"Joanna Pancewicz , Paweł Golec , Anetta Sulewska , Radoslaw Charkiewicz , Wieslawa Niklinska , Piotr Michal Chodorowski , Miroslaw Kozlowski","doi":"10.1016/j.advms.2025.12.002","DOIUrl":"10.1016/j.advms.2025.12.002","url":null,"abstract":"<div><h3>Purpose</h3><div>The Wnt/β-catenin signaling pathway is frequently deregulated in various malignancies, including non-small cell lung cancer (NSCLC). This study aimed to evaluate the expression levels of genes encoding ligands that are typically associated with the non-canonical Wnt/β-catenin pathways, specifically, <em>WNT-4</em>, <em>WNT-5A</em>, <em>WNT-7A</em>, <em>WNT-11</em>, and <em>WNT-16</em> in NSCLC.</div></div><div><h3>Materials and methods</h3><div>The analysis was conducted on 80 matched pairs of tumor and adjacent non-cancerous lung tissues. Quantitative gene expression analysis was performed using real-time polymerase chain reaction (qPCR).</div></div><div><h3>Results</h3><div>The results revealed a consistent reduction in the expression of all investigated genes across NSCLC samples and their respective histological subtypes. Notably, elevated <em>WNT-7A</em> gene expression was observed between clinical early (IA) and intermediate IIA stages of NSCLC.</div></div><div><h3>Conclusions</h3><div>These findings suggest that alterations in the expression of non-canonical Wnt/β-catenin pathway ligands are integral to lung carcinogenesis and may play a critical role in the development of NSCLC. The observed changes in <em>WNT-7A</em> expression between IA and IIA stages of NSCLC further indicate its potential involvement in tumor progression.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"71 1","pages":"Pages 10-18"},"PeriodicalIF":2.6,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145832099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-16DOI: 10.1016/j.advms.2025.12.001
Bahar Kartal , Uygar Saçik , Güven Erbil
{"title":"Corrigendum to “Investigation of the effects of umbilical cord and adipose-derived mesenchymal stem cells on endoplasmic reticulum stress in cadmium-induced rat kidney” [Adv. Med. Sci. (2025 Oct) 70 (2) 284-290]","authors":"Bahar Kartal , Uygar Saçik , Güven Erbil","doi":"10.1016/j.advms.2025.12.001","DOIUrl":"10.1016/j.advms.2025.12.001","url":null,"abstract":"","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"71 1","pages":"Page 9"},"PeriodicalIF":2.6,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145779815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-28DOI: 10.1016/j.advms.2025.11.002
Kamil Kiecka , Aleksandra Zygula , Anna Sankiewicz , Mariusz Kuzmicki , Slawomir Lawicki , Michal Ciebiera , Tadeusz Issat , Jan Blaszczyk , Krzysztof Cendrowski , Ewa Gorodkiewicz , Piotr Laudanski
Purpose
Endometriosis is a prevalent gynecological condition often requiring invasive procedures for diagnosis. This study aimed to assess mesothelin (MSLN) as a potential non-invasive biomarker by analyzing its levels in peritoneal fluid (PF) and plasma.
Materials/methods
In a multicenter cross-sectional study, MSLN concentrations were measured using Surface Plasmon Resonance imaging (SPRi) biosensors in samples from women undergoing laparoscopy for pelvic pain or infertility.
Results
Significantly higher MSLN levels were observed in the PF of patients with endometriosis compared to controls (mean concentrations: 10.24 vs. 9.39 ng/mL, p = 0.038). The elevation was particularly notable in patients with stage I and II endometriosis compared to the control group (mean concentrations: 10.83 vs. 9.39 ng/mL, p = 0.049). No significant differences were observed in plasma.
Conclusions
Mesothelin in PF may be considered as a potential biomarker for endometriosis, especially in its early stages. Further studies are needed to confirm its diagnostic value.
目的:子宫内膜异位症是一种常见的妇科疾病,通常需要侵入性手术来诊断。本研究旨在通过分析腹膜液(PF)和血浆中间皮素(MSLN)的水平来评估其作为一种潜在的非侵入性生物标志物的价值。材料/方法:在一项多中心横断面研究中,使用表面等离子体共振成像(SPRi)生物传感器测量盆腔疼痛或不孕症妇女腹腔镜检查样本中的MSLN浓度。结果:与对照组相比,子宫内膜异位症患者PF中MSLN水平显著升高(平均浓度:10.24 vs. 9.39 ng/mL, p = 0.038)。与对照组相比,I期和II期子宫内膜异位症患者的升高尤为显著(平均浓度:10.83 vs. 9.39 ng/mL, p = 0.049)。血浆中未见明显差异。结论:间皮素可能被认为是子宫内膜异位症的潜在生物标志物,特别是在其早期阶段。其诊断价值有待进一步研究证实。
{"title":"Mesothelin as a diagnostic biomarker in endometriosis: A cross-sectional study","authors":"Kamil Kiecka , Aleksandra Zygula , Anna Sankiewicz , Mariusz Kuzmicki , Slawomir Lawicki , Michal Ciebiera , Tadeusz Issat , Jan Blaszczyk , Krzysztof Cendrowski , Ewa Gorodkiewicz , Piotr Laudanski","doi":"10.1016/j.advms.2025.11.002","DOIUrl":"10.1016/j.advms.2025.11.002","url":null,"abstract":"<div><h3>Purpose</h3><div>Endometriosis is a prevalent gynecological condition often requiring invasive procedures for diagnosis. This study aimed to assess mesothelin (MSLN) as a potential non-invasive biomarker by analyzing its levels in peritoneal fluid (PF) and plasma.</div></div><div><h3>Materials/methods</h3><div>In a multicenter cross-sectional study, MSLN concentrations were measured using Surface Plasmon Resonance imaging (SPRi) biosensors in samples from women undergoing laparoscopy for pelvic pain or infertility.</div></div><div><h3>Results</h3><div>Significantly higher MSLN levels were observed in the PF of patients with endometriosis compared to controls (mean concentrations: 10.24 vs. 9.39 ng/mL, p = 0.038). The elevation was particularly notable in patients with stage I and II endometriosis compared to the control group (mean concentrations: 10.83 vs. 9.39 ng/mL, p = 0.049). No significant differences were observed in plasma.</div></div><div><h3>Conclusions</h3><div>Mesothelin in PF may be considered as a potential biomarker for endometriosis, especially in its early stages. Further studies are needed to confirm its diagnostic value.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"71 1","pages":"Pages 1-8"},"PeriodicalIF":2.6,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145646923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Spondyloarthropathies (SpA) are a broad and diverse group of diseases with highly variable clinical manifestations. Due to this wide range of symptoms and their frequent overlap with other disease entities, SpA present numerous diagnostic and therapeutic challenges. Moreover, the pathogenesis of SpA remains unexplained. While the currently prevailing hypothesis suggests an autoinflammatory mechanism, the involvement of autoimmune processes has not been ruled out. To explore this possibility, the present study aimed to assess the presence of antinuclear antibodies (ANA) and their clinical associations in patients with SpA.
Patients and methods
The analysis included 117 consecutive patients with different forms of SpA, i.e., ankylosing spondylitis (n = 52), psoriatic arthritis (n = 34), and non-radiographic SpA (n = 31). They underwent clinical evaluation, and serum samples were collected from each for ANA testing using indirect immunofluorescence.
Results
ANA were found in 46 % of patients with SpA. No statistically significant association was found between ANA and diagnosis of specific SpA or clinical symptoms. Interestingly, the highest prevalence of ANA (63 %) was found in women with non-radiographic spondyloarthropathy and the lowest (38 %) in males with ankylosing spondylitis, however, the difference did not reach statistical significance.
Conclusion
The results of our study suggest that ANA are frequent in patients with SpA, in particular in women with early, non-radiographic SpA which may be of clinical significance. However, further studies, involving larger populations, are necessary to clarify the significance of ANA presence in SpA patients.
{"title":"Prevalence and clinical associations of antinuclear antibodies (ANA) in spondyloarthropathies","authors":"Adrianna Błahuszewska-Omyła , Emilia Frąckiel , Marek Bielecki , Ewa Gińdzieńska- Sieśkiewicz , Natalia Szymańska , Otylia Kowal-Bielecka","doi":"10.1016/j.advms.2025.09.005","DOIUrl":"10.1016/j.advms.2025.09.005","url":null,"abstract":"<div><h3>Purpose</h3><div>Spondyloarthropathies (SpA) are a broad and diverse group of diseases with highly variable clinical manifestations. Due to this wide range of symptoms and their frequent overlap with other disease entities, SpA present numerous diagnostic and therapeutic challenges. Moreover, the pathogenesis of SpA remains unexplained. While the currently prevailing hypothesis suggests an autoinflammatory mechanism, the involvement of autoimmune processes has not been ruled out. To explore this possibility, the present study aimed to assess the presence of antinuclear antibodies (ANA) and their clinical associations in patients with SpA.</div></div><div><h3>Patients and methods</h3><div>The analysis included 117 consecutive patients with different forms of SpA, i.e., ankylosing spondylitis (n = 52), psoriatic arthritis (n = 34), and non-radiographic SpA (n = 31). They underwent clinical evaluation, and serum samples were collected from each for ANA testing using indirect immunofluorescence.</div></div><div><h3>Results</h3><div>ANA were found in 46 % of patients with SpA. No statistically significant association was found between ANA and diagnosis of specific SpA or clinical symptoms. Interestingly, the highest prevalence of ANA (63 %) was found in women with non-radiographic spondyloarthropathy and the lowest (38 %) in males with ankylosing spondylitis, however, the difference did not reach statistical significance.</div></div><div><h3>Conclusion</h3><div>The results of our study suggest that ANA are frequent in patients with SpA, in particular in women with early, non-radiographic SpA which may be of clinical significance. However, further studies, involving larger populations, are necessary to clarify the significance of ANA presence in SpA patients.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"70 2","pages":"Pages 377-381"},"PeriodicalIF":2.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145090759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study aimed to present real-world data regarding the treatment of inflammatory bowel disease (IBD) with the subcutaneous (SC) formulation of the tumor necrosis factor inhibitor, infliximab.
Methods
Adult IBD patients who switched from intravenous (IV) infliximab to SC infliximab were recruited for this study. Data on the efficacy of maintaining long-term remission, persistence in therapy and the safety profile were obtained from medical records and physician assessments conducted during routine clinical practice. Data on adherence to treatment schedules and patient satisfaction were collected through an ad hoc questionnaire. The duration of the follow-up was 12 months.
Results
The treatment with SC infliximab was generally well-tolerated, with a persistence rate of 86.7 % at 12 months and adherence to the treatment schedule of 86.4 %. Patients reported a favorable experience with self-injections. Mild, self-limiting adverse events were observed, and inflammatory biomarkers decreased over time, suggesting maintenance of remission in most patients.
Conclusions
The findings suggest that SC infliximab may be a viable option for IBD patients in remission who are eligible for switching, offering a self-administered alternative to IV therapy.
{"title":"The transition from intravenous to subcutaneous infliximab in a cohort of patients with inflammatory bowel disease: results of the INESTIMABLE retrospective observational study","authors":"Alessia Todeschini , Andrea Geccherle , Paola Signoretto , Nicoletta Colaci , Federica Mellone , Nicoletta De Santis , Massimo Guerriero , Giuliano Barugola , Angela Variola","doi":"10.1016/j.advms.2025.10.001","DOIUrl":"10.1016/j.advms.2025.10.001","url":null,"abstract":"<div><h3>Purpose</h3><div>This study aimed to present real-world data regarding the treatment of inflammatory bowel disease (IBD) with the subcutaneous (SC) formulation of the tumor necrosis factor inhibitor, infliximab.</div></div><div><h3>Methods</h3><div>Adult IBD patients who switched from intravenous (IV) infliximab to SC infliximab were recruited for this study. Data on the efficacy of maintaining long-term remission, persistence in therapy and the safety profile were obtained from medical records and physician assessments conducted during routine clinical practice. Data on adherence to treatment schedules and patient satisfaction were collected through an <em>ad hoc</em> questionnaire. The duration of the follow-up was 12 months.</div></div><div><h3>Results</h3><div>The treatment with SC infliximab was generally well-tolerated, with a persistence rate of 86.7 % at 12 months and adherence to the treatment schedule of 86.4 %. Patients reported a favorable experience with self-injections. Mild, self-limiting adverse events were observed, and inflammatory biomarkers decreased over time, suggesting maintenance of remission in most patients.</div></div><div><h3>Conclusions</h3><div>The findings suggest that SC infliximab may be a viable option for IBD patients in remission who are eligible for switching, offering a self-administered alternative to IV therapy.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"70 2","pages":"Pages 392-400"},"PeriodicalIF":2.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145273320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Despite ongoing debate surrounding mesenchymal stem/stromal cells (MSCs), the number of clinical trials involving MSCs has continued to increase due to their strong therapeutic potential. These cells exhibit immunosuppressive and neuroprotective properties, making them a promising approach for treating neurodegenerative diseases. Given the growing interest in stem cell-based therapies, it is essential to establish specific protocols for manufacturing adipose-derived MSCs. This study outlines the process of obtaining an ATMP cell product from ASCs, evaluating cell quality, isolation efficiency, and optimal conditions for cryopreservation, preparation, and transport.
Materials and methods
Cells were isolated from fresh, cryopreserved, and 4°C-stored adipose tissue to evaluate how different storage conditions affect cell quality. In addition, cell viability in different transport solutions over time was examined. To evaluate the therapeutic potential of ASCs, cells were cultured in cerebrospinal fluid (CSF) and neural gene and protein expression, as well as the secretome profile, were analysed.
Results
Our findings show that isolating ASCs immediately after liposuction yields the highest viable cell count. Adipose tissue can be stored at 4 °C for up to 48 h without affecting cell population doubling time, but cryopreservation negatively impacts ASCs’ clonogenicity. For optimal long-term preservation, a medium with 5 % platelet lysate and 10 % DMSO is recommended. Additionally, we found that 0.9 % NaCl is the best transport medium for maintaining cell viability. CSF exposure induced neural markers (NG2, A2B5, Nestin, β-III-tubulin, S-100-β) and morphological changes, suggesting neural-like differentiation.
Conclusions
These findings contribute to the development of protocols for MSC therapy in neurodegenerative diseases.
尽管围绕间充质干细胞(MSCs)的争论仍在继续,但由于其强大的治疗潜力,涉及MSCs的临床试验数量不断增加。这些细胞表现出免疫抑制和神经保护特性,使它们成为治疗神经退行性疾病的有希望的方法。鉴于对干细胞疗法的兴趣日益增长,建立制造脂肪来源的间充质干细胞的特定方案至关重要。本研究概述了从ASCs中获得ATMP细胞产品的过程,评估了细胞质量、分离效率以及冷冻保存、制备和运输的最佳条件。材料和方法从新鲜、低温保存和4°c储存的脂肪组织中分离细胞,以评估不同储存条件对细胞质量的影响。此外,随着时间的推移,细胞活力在不同的运输溶液进行了检查。为了评估ASCs的治疗潜力,在脑脊液(CSF)中培养细胞,分析神经基因和蛋白质表达以及分泌组谱。结果吸脂后立即分离ASCs可获得最高的活细胞计数。脂肪组织可在4℃下保存48小时,不影响细胞群体倍增时间,但低温保存会对ASCs的克隆原性产生负面影响。为了获得最佳的长期保存,推荐使用含有5%血小板裂解液和10% DMSO的培养基。此外,我们发现0.9% NaCl是维持细胞活力的最佳运输培养基。脑脊液暴露诱导神经标记物(NG2、A2B5、Nestin、β- iii -微管蛋白、S-100-β)和形态学改变,提示神经样分化。结论这些发现有助于MSC治疗神经退行性疾病方案的发展。
{"title":"Enhancing the clinical potential: Quality assessment of adipose tissue-derived Mesenchymal Stem/Stromal Cells for therapeutic use","authors":"Monika Rytel , Magdalena Chodkowska-Michalowska , Dorota Sulejczak , Natalia Krześniak , Marzena Zychowicz , Anna Sarnowska","doi":"10.1016/j.advms.2025.10.002","DOIUrl":"10.1016/j.advms.2025.10.002","url":null,"abstract":"<div><h3>Purpose</h3><div>Despite ongoing debate surrounding mesenchymal stem/stromal cells (MSCs), the number of clinical trials involving MSCs has continued to increase due to their strong therapeutic potential. These cells exhibit immunosuppressive and neuroprotective properties, making them a promising approach for treating neurodegenerative diseases. Given the growing interest in stem cell-based therapies, it is essential to establish specific protocols for manufacturing adipose-derived MSCs. This study outlines the process of obtaining an ATMP cell product from ASCs, evaluating cell quality, isolation efficiency, and optimal conditions for cryopreservation, preparation, and transport.</div></div><div><h3>Materials and methods</h3><div>Cells were isolated from fresh, cryopreserved, and 4°C-stored adipose tissue to evaluate how different storage conditions affect cell quality. In addition, cell viability in different transport solutions over time was examined. To evaluate the therapeutic potential of ASCs, cells were cultured in cerebrospinal fluid (CSF) and neural gene and protein expression, as well as the secretome profile, were analysed.</div></div><div><h3>Results</h3><div>Our findings show that isolating ASCs immediately after liposuction yields the highest viable cell count. Adipose tissue can be stored at 4 °C for up to 48 h without affecting cell population doubling time, but cryopreservation negatively impacts ASCs’ clonogenicity. For optimal long-term preservation, a medium with 5 % platelet lysate and 10 % DMSO is recommended. Additionally, we found that 0.9 % NaCl is the best transport medium for maintaining cell viability. CSF exposure induced neural markers (NG2, A2B5, Nestin, β-III-tubulin, S-100-β) and morphological changes, suggesting neural-like differentiation.</div></div><div><h3>Conclusions</h3><div>These findings contribute to the development of protocols for MSC therapy in neurodegenerative diseases.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"70 2","pages":"Pages 408-424"},"PeriodicalIF":2.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145473604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.advms.2025.10.004
Artur Dziewierz , Barbara Zdzierak , Roman M. Wojdyła
{"title":"Letter to the editor: “Structured team response and sex-based mortality gaps in acute pulmonary embolism: Conflicting evidence and future directions”","authors":"Artur Dziewierz , Barbara Zdzierak , Roman M. Wojdyła","doi":"10.1016/j.advms.2025.10.004","DOIUrl":"10.1016/j.advms.2025.10.004","url":null,"abstract":"","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"70 2","pages":"Pages 425-426"},"PeriodicalIF":2.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145450459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}